Man Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.19M | Buy |
286,933
+90,615
| +46% | +$1.95M | 0.01% | 825 |
|
2025
Q1 | $3.26M | Sell |
196,318
-1,024,704
| -84% | -$17M | 0.01% | 1017 |
|
2024
Q4 | $22.4M | Sell |
1,221,022
-54,411
| -4% | -$998K | 0.06% | 336 |
|
2024
Q3 | $19.6M | Buy |
1,275,433
+1,218,288
| +2,132% | +$18.7M | 0.05% | 424 |
|
2024
Q2 | $929K | Buy |
57,145
+6,844
| +14% | +$111K | ﹤0.01% | 1402 |
|
2024
Q1 | $930K | Buy |
50,301
+18,081
| +56% | +$334K | ﹤0.01% | 1457 |
|
2023
Q4 | $1.01M | Buy |
+32,220
| New | +$1.01M | ﹤0.01% | 1337 |
|
2023
Q3 | – | Sell |
-277,196
| Closed | -$6.64M | – | 1202 |
|
2023
Q2 | $6.64M | Buy |
+277,196
| New | +$6.64M | 0.02% | 758 |
|
2023
Q1 | – | Sell |
-955,688
| Closed | -$15.2M | – | 471 |
|
2022
Q4 | $15.2M | Buy |
955,688
+932,503
| +4,022% | +$14.8M | 0.05% | 414 |
|
2022
Q3 | $379K | Buy |
+23,185
| New | +$379K | ﹤0.01% | 1568 |
|
2022
Q2 | – | Sell |
-19,436
| Closed | -$470K | – | 1979 |
|
2022
Q1 | $470K | Buy |
+19,436
| New | +$470K | ﹤0.01% | 1575 |
|
2021
Q1 | – | Sell |
-50,129
| Closed | -$2.68M | – | 1824 |
|
2020
Q4 | $2.68M | Sell |
50,129
-9,131
| -15% | -$488K | 0.01% | 1086 |
|
2020
Q3 | $2.44M | Sell |
59,260
-56,160
| -49% | -$2.32M | 0.01% | 1122 |
|
2020
Q2 | $5.59M | Buy |
115,420
+65,835
| +133% | +$3.19M | 0.03% | 610 |
|
2020
Q1 | $2.1M | Sell |
49,585
-37,732
| -43% | -$1.59M | 0.01% | 863 |
|
2019
Q4 | $3.74M | Buy |
+87,317
| New | +$3.74M | 0.01% | 1101 |
|
2019
Q2 | – | Sell |
-48,215
| Closed | -$1.29M | – | 1861 |
|
2019
Q1 | $1.29M | Sell |
48,215
-1,646
| -3% | -$44.2K | ﹤0.01% | 1488 |
|
2018
Q4 | $806K | Buy |
+49,861
| New | +$806K | ﹤0.01% | 1511 |
|
2018
Q2 | – | Sell |
-6,314
| Closed | -$142K | – | 2078 |
|
2018
Q1 | $142K | Buy |
+6,314
| New | +$142K | ﹤0.01% | 1926 |
|